WorldPing
WorldPingSTAT
STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns
The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.
Brief by WorldPing · Original reporting by STAT
STAT
STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
WorldPingPresident Trump’s pledge to make pricey weight loss drugs widely available for low-income Americans through Medicaid is not panning out…
This is a short WorldPing brief. The full report was published by STAT.
Read the full report at STATRelated news
WorldPing
WorldPingSTAT
STAT+: Medicaid transgender care rule sets precedent that could restrict coverage of other drugs
The legal theory used to restrict gender-affirming care for minors could be applied broadly, experts say.
Brief by WorldPing · Original reporting by STAT
ESPN
Wetzel: Mad about CFB eligibility chaos? The NCAA should have seen it coming
The NCAA's well-intentioned but clumsily executed "five for five" decision made going from the NFL back to college inevitable.
Brief by WorldPing · Original reporting by ESPN
ESPN
Takeaways from NFL preseason Week 2: Even with win, should Titans be worried about revamped secondary?
NFL Nation reporters tackle the biggest looming roster questions coming off each NFL Week 2 preseason game.
Brief by WorldPing · Original reporting by ESPN
WorldPingCryptoSlate
BitMart is talking about reopening before it has answered the withdrawal question
The plan may revive some operations, but it has not canceled the exchange’s trading halt or withdrawal recommendation.
Brief by WorldPing · Original reporting by CryptoSlate
WorldPingTimes of India
Cowherd raises concerns about Patrick Mahomes future ahead of Chiefs return
Patrick Mahomes could be gearing up or his biggest season but popular analyst Colin Cowherd raises serious concerns about his fitness.
Brief by WorldPing · Original reporting by Times of India